骨髓穿刺濃縮液(BMAC)的全球市場 - 成長、趨勢、預測(2020年∼2025年)
Bone Marrow Aspirate Concentrates Market - Growth, Trends, and Forecast (2020 - 2025)
|出版商||Mordor Intelligence LLP||商品編碼||921889|
|出版日期||內容資訊||英文 112 Pages
|骨髓穿刺濃縮液(BMAC)的全球市場 - 成長、趨勢、預測(2020年∼2025年) Bone Marrow Aspirate Concentrates Market - Growth, Trends, and Forecast (2020 - 2025)|
|出版日期: 2020年01月01日||內容資訊: 英文 112 Pages||
The bone marrow aspirate concentrates market is expected to grow with a CAGR of 5.0%, during the forecast period. Bone marrow aspirate concentrate is made from the fluid which is taken from bone marrow. Bone marrow aspirate concentrate represents mononuclear cell concentration, red blood cell, immature myeloid precursors, granulocytes, and platelets which are derived through a minimally invasive procedure that avoids the risks of an open bone graft procedure and this cells can help in the healing of some bone and joint conditions. Increased prevalence of orthopedic diseases and sports injuries, with high growth of the cosmetic surgery industry and increasing applications of the bone marrow aspirate concentrate (BMAC) products in the cosmetic and orthopedic surgeries, are driving the growth of the bone marrow aspirate concentrate market.
Rising prevalence of osteoarthritis globally, due to the ageing population. According to the United Nations by the year 2050, people over 60 years age will account for more than 20% of the world's population, of which 130 million people will suffer from osteoarthritis worldwide, of whom 40 million will be severely disabled by the disease.
New technological advancements, favorable government regulations and increasing prevalence of orthopedic diseases are the factors that may further contribute to the bone marrow aspirate concentrate market growth. However, the high failure rate is likely to restrain the market growth in the forecast period.
Bone marrow aspirate concentrate is made from the fluid which is taken from bone marrow. Bone Marrow Aspirate Concentrates are segmented by Product (Bone Marrow Aspirate Concentrates Systems, Bone Marrow Aspirate Concentrates Accessories), Application and Geography.
Orthopedic Surgery Segment is Expected to Hold a Significant Market Share in the Bone Marrow Aspirate Concentrates
North America is Expected to Dominate the Market and Expected to do Same in the Forecast Period
North America is expected to hold a major share globally in the bone marrow aspirate concentrates market due to rising prevalence of osteoarthritis diseases, rise in technological advancements and awareness about stem cell therapy in this region. Osteoarthritis (OA) is the most common joint disorder in the United States which occurs in 10% men and 13% in women aged 60 years or older. According to The Osteoarthritis Research Society International by the year 2030, an estimated 67 million adults aged 18 years and older will have doctor-diagnosed osteoarthritis. Furthermore, increasing the incidence of osteoarthritis diseases and a growing geriatric population in the country is fueling the growth of the overall regional market to a large extent.
The Bone Marrow Aspirate Concentrates Market is moderately consolidated and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some players are adopting numerous strategies including acquisitions and collaborations to sustain competitive advantage. Some of the companies which are currently dominating the market are Ranfac Corp, Arthrex, Inc, Globus Medical, Inc, Terumo Corporation (Terumo BCT), Cesca Therapeutics Inc, Zimmer Biomet Holdings, Inc, MK Alliance Inc. (TotipotentSC), MED & CARE Innovative Solutions, Aspire Medical Innovation and EmCyte Corporation.